Home > Insider Trading > Filing (0001179110-15-012105)

Filing Details

Accession Number:: 0001179110-15-012105
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-13 19:50:48
Reporting Period:: 2015-08-11

Filing Date:: 2015-08-13
Accepted Time:: 2015-08-13 19:50:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1423824	Alder Biopharmaceuticals Inc	ALDR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1026496	W Jon Bayless	C/O Sevin Rosen Funds 13455 Noel Road, Suite 1670 Dallas TX 75240	No	No	No	Yes
1033563	V John Jaggers	C/O Sevin Rosen Funds 13355 Noel Road, Suite 1350 Dallas TX 75240	No	No	No	Yes
1066600	R Alan Schuele	C/O Sevin Rosen Funds 13455 Noel Road, Suite 1670 Dallas TX 75240	No	No	No	Yes
1189256	L Stephen Domenik	C/O Sevin Rosen Funds 13455 Noel Road, Suite 1670 Dallas TX 75240	No	No	No	Yes
1189257	R Jackie Kimzey	Sevin Rosen Funds 13355 Noel Road, Suite 1350 Dallas TX 75240	No	No	No	Yes
1205949	T John Oxaal	C/O Sevin Rosen Funds 13455 Noel Road, Suite 1670 Dallas TX 75240	No	No	No	Yes
1205951	G Nicholas Sturiale	C/O Sevin Rosen Funds 13455 Noel Road, Suite 1670 Dallas TX 75240	No	No	No	Yes
1425210	J. David Mclean	C/O Sevin Rosen Funds 13455 Noel Road, Suite 1670 Dallas TX 75240	No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-08-11	115,358	$40.40	1,909,125	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-12	97,109	$40.03	1,812,016	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-08-12	1,795,752	$0.00	16,264	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2015-08-12	42	$0.00	16,306	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2015-08-12	4,115	$0.00	8,662	No	4	J	Direct
Common Stock	Acquisiton	2015-08-12	1,259	$0.00	2,651	No	4	J	Direct
Common Stock	Acquisiton	2015-08-12	3,316	$0.00	6,980	No	4	J	Direct
Common Stock	Acquisiton	2015-08-12	3,316	$0.00	6,980	No	4	J	Direct
Common Stock	Acquisiton	2015-08-15	2,517	$0.00	5,299	No	4	J	Direct
Common Stock	Acquisiton	2015-08-12	2,118	$0.00	4,458	No	4	J	Direct
Common Stock	Acquisiton	2015-08-12	4,115	$0.00	8,662	No	4	J	Direct
Common Stock	Acquisiton	2015-08-12	2,118	$0.00	4,458	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct

Footnotes

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.90 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Total Common Shares of 1,909,125 represents 46 shares owned directly by SRB Associates IX L.P. ("SRBAIX"), 1,860,948 shares owned directly by Sevin Rosen Fund IX L.P. ("SRFIX"), 48,131 shares owned directly by Sevin Rosen IX Affiliates Fund L.P. ("SRFIX AFF"). John V. Jaggers ("Jaggers"), Jon W. Bayless ("Bayless") Stephen L. Domenik, ("Domenik"), Jackie R.Kimzey ("Kimzey") David J. McLean ("McLean"), John T. Oxaal ("Oxaal"), Alan R. Schuele ("Schuele") and Nicholas G. Sturiale ("Sturiale") are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.26 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Total Common Shares of 1,812,016 represents 46 shares owned directly by SRBAIX, 1,765,877 shares owned directly by SRFIX and 46,093 shares owned directly by SRFIX AFF. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
Represents a pro-rata in-kind distribution, without additional consideration, of 1,750,000 shares of Common Stock of the Issuer by SRFIX and 45,752 shares of Common Stock of the Issuer by SRIXAFF.
Total Common Shares of 16,264 represents 46 shares owned directly by SRBAIX, 15,877 shares owned directly by SRFIX and 341 shares owned directly by SRIX AFF. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
Represents the receipt of shares by SRBAIX of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
Total Common Shares of 16,306 represents 88 shares owned directly by SRBAIX, 15,877 shares owned directly by SRFIX and 341 shares owned directly by SRIX AFF. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
Represents the receipt of shares by Jaggers of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
Represents the receipt of shares by Bayless of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
Represents the receipt of shares by Domenik of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
Represents the receipt of shares by Kimzey of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
Represents the receipt of shares by McLean of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
Represents the receipt of shares by Oxaal of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
Represents the receipt of shares by Schuele of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
Represents the receipt of shares by Sturiale of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.